menu
    • menu

    Company profile for Taysha Gene Therapies

    NEW Drugs in Dev: 7
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipe...
    Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. T

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Taysha Gene TherapiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    BioCenter at UT Southwestern 2280 Inwood Rd, Dallas, TX 75235
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tayshagtx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taysha Gene Therapies Grants Inducement Under Nasdaq Lr
    Taysha Gene Therapies Grants Inducement Under Nasdaq Lr

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233772/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Taysha Gene Therapies Advances TSHA-102 Gene Therapy For Rett
    Taysha Gene Therapies Advances TSHA-102 Gene Therapy For Rett

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213539/0/en/Taysha-Gene-Therapies-Announces-Progress-Across-TSHA-102-Pivotal-Gene-Therapy-Program-in-Rett-Syndrome.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Taysha Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
    Taysha Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200980/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Taysha Gene Therapies To Unveil Q3 2025 Financials
    Taysha Gene Therapies To Unveil Q3 2025 Financials

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175325/0/en/Taysha-Gene-Therapies-to-Release-Third-Quarter-2025-Financial-Results-and-Host-Conference-Call-and-Webcast-on-November-4.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Astellas Turns Down Option To License Taysha Gene Therapy—Again
    Astellas Turns Down Option To License Taysha Gene Therapy—Again

    17 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astellas-walks-away-gene-therapy-pact-taysha-pivotal-trial-launch

    FIERCE BIOTECH
    17 Oct 2025
    Share Share
    Taysha Gene Takes Back Control Of TSHA-102 For Rett Syndrome
    Taysha Gene Takes Back Control Of TSHA-102 For Rett Syndrome

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3168291/0/en/Taysha-Gene-Therapies-Regains-Full-Rights-to-Lead-TSHA-102-Program-in-Clinical-Evaluation-for-the-Treatment-of-Rett-Syndrome.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search